Security key
75382E109
RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RAPT)
CUSIP: 75382E109
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 27,725,634
- Total 13F shares
- 29,739,176
- Share change
- +1,719,653
- Total reported value
- $542,744,027
- Put/Call ratio
- 25%
- Price per share
- $18.25
- Number of holders
- 83
- Value change
- +$30,137,398
- Number of buys
- 41
- Number of sells
- 35
Report period
Q2 2022
Institutions
83
Top holders
10
RAPT full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
RAPT Therapeutics, Inc. SEC filings
RAPT Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75382E109
Recent filing periods:
Top shareholders of RAPT - RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
14%
|
3,974,705
|
$87,404,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
11%
|
3,182,701
|
$69,988,000 | — | 31 Mar 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
10%
|
2,799,962
|
$61,571,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.5%
|
1,801,860
|
$39,623,000 | — | 31 Mar 2022 | |
| Ponoi Management, LLC |
13F
|
Company |
5.8%
|
1,599,417
|
$35,171,000 | — | 31 Mar 2022 | |
| Column Group LLC |
13F
|
Company |
5.1%
|
1,402,008
|
$30,830,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
4.9%
|
1,347,581
|
$29,633,000 | — | 31 Mar 2022 | |
| KPCB XV Associates, LLC |
13F
|
Company |
4.7%
|
1,297,063
|
$28,522,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.4%
|
1,224,545
|
$26,928,000 | — | 31 Mar 2022 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
3.9%
|
1,088,321
|
$23,932,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
3.8%
|
1,055,957
|
$23,222,000 | — | 31 Mar 2022 | |
| Redmile Group, LLC |
13F
|
Company |
2.7%
|
748,677
|
$16,463,000 | — | 31 Mar 2022 | |
| Alphabet Inc. |
13F
|
Company |
1.9%
|
540,270
|
$11,881,000 | — | 31 Mar 2022 | |
| Of The University Of California Regents |
13F
|
Individual |
1.6%
|
443,619
|
$9,755,000 | — | 31 Mar 2022 | |
| Euclidean Capital LLC |
13F
|
Company |
1.6%
|
432,900
|
$9,519,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
370,591
|
$8,149,000 | — | 31 Mar 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.3%
|
361,300
|
$7,945,000 | — | 31 Mar 2022 | |
| Woodline Partners LP |
13F
|
Company |
1.3%
|
358,443
|
$7,882,000 | — | 31 Mar 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.1%
|
302,682
|
$6,656,000 | — | 31 Mar 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1%
|
288,336
|
$6,341,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1%
|
285,325
|
$6,274,000 | — | 31 Mar 2022 | |
| HealthCor Management, L.P. |
13F
|
Company |
0.95%
|
264,150
|
$5,809,000 | — | 31 Mar 2022 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.9%
|
250,000
|
$5,498,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.76%
|
212,029
|
$4,662,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.72%
|
200,800
|
$4,416,000 | — | 31 Mar 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.57%
|
157,764
|
$3,469,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.53%
|
145,818
|
$3,207,000 | — | 31 Mar 2022 | |
| Ponoi II Management, LLC |
13F
|
Company |
0.52%
|
145,401
|
$3,197,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.52%
|
145,336
|
$3,030,000 | — | 31 Mar 2022 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.4%
|
110,000
|
$2,419,000 | — | 31 Mar 2022 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.36%
|
101,000
|
$2,221,000 | — | 31 Mar 2022 | |
| AJU IB Investment Co., Ltd. |
13F
|
Company |
0.36%
|
99,503
|
$2,188,000 | — | 31 Mar 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.35%
|
98,045
|
$2,156,000 | — | 31 Mar 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.3%
|
83,733
|
$1,841,000 | — | 31 Mar 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.28%
|
78,788
|
$1,733,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.28%
|
78,521
|
$1,727,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.26%
|
73,318
|
$1,612,000 | — | 31 Mar 2022 | |
| Walleye Capital LLC |
13F
|
Company |
0.24%
|
66,001
|
$1,451,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
65,787
|
$1,447,000 | — | 31 Mar 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.2%
|
55,082
|
$1,202,498 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.18%
|
50,602
|
$1,112,000 | — | 31 Mar 2022 | |
| Jasper Ridge Partners, L.P. |
13F
|
Company |
0.16%
|
45,650
|
$1,004,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.16%
|
45,500
|
$1,001,000 | — | 31 Mar 2022 | |
| Swiss National Bank |
13F
|
Company |
0.16%
|
45,400
|
$998,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
44,962
|
$989,000 | — | 31 Mar 2022 | |
| J. Goldman & Co LP |
13F
|
Company |
0.14%
|
39,491
|
$868,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.13%
|
36,123
|
$794,000 | — | 31 Mar 2022 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.11%
|
30,395
|
$668,000 | — | 31 Mar 2022 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.1%
|
28,500
|
$627,000 | — | 31 Mar 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
28,100
|
$618,000 | — | 31 Mar 2022 |
Institutional Holders of RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RAPT) as of Q2 2022
As of 30 Jun 2022,
RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RAPT) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,739,176 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Column Group LLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, Ponoi Management, LLC, KPCB XV Associates, LLC, VANGUARD GROUP INC, MORGAN STANLEY, and KINGDON CAPITAL MANAGEMENT, L.L.C..
This page lists
83
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
82
Q2 2022 holders
83
Holder diff
1
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.